MAVS and systemic lupus erythematosus: Moreover, in the same study, the MAVS-C79F variant failed to oligomerize and showed exhibited milder forms of SLE, suggesting that the inhibition of spontaneous MAVS oligomerization might be a therapeutic target in SLE12,13.